Search Results

Filter
  • 1-10 of  1,010 results for ""Xenograft Model Antitumor Assays""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Antitumor activities of anti‑CD44 monoclonal antibodies in mouse xenograft models of esophageal cancer.

  • Authors : Ishikawa K; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Aoba‑ku, Sendai, Miyagi 980‑8575, Japan.; Suzuki H

Subjects: Hyaluronan Receptors*/Hyaluronan Receptors*/Hyaluronan Receptors*/immunology ; Hyaluronan Receptors*/Hyaluronan Receptors*/Hyaluronan Receptors*/metabolism ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/drug therapy

  • Source: Oncology reports [Oncol Rep] 2024 Nov; Vol. 52 (5). Date of Electronic Publication: 2024 Sep 02.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer.

  • Authors : Wang YW; Department of Food Safety Hygiene and Risk Management, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan, R.O.C.; Tuan YL

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics

  • Source: Oncology reports [Oncol Rep] 2025 Jan; Vol. 53 (1). Date of Electronic Publication: 2024 Nov 29.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Energy‑stress‑mediated activation of AMPK sensitizes MPS1 kinase inhibition in triple‑negative breast cancer.

  • Authors : Lim JS; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.; Kim E

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/pathology ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/metabolism

  • Source: Oncology reports [Oncol Rep] 2024 Aug; Vol. 52 (2). Date of Electronic Publication: 2024 Jun 21.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Ursolic acid inhibits the proliferation of triple‑negative breast cancer stem‑like cells through NRF2‑mediated ferroptosis.

  • Authors : Yang X; Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China.; Liang B

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/drug effects ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/pathology

  • Source: Oncology reports [Oncol Rep] 2024 Jul; Vol. 52 (1). Date of Electronic Publication: 2024 Jun 07.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Enhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral delivery.

  • Authors : Zheng D; Department of Nephrology, Huai'an Hospital Affiliated to Xuzhou Medical College and Huai'an Second Hospital, Huai'an 223002, P.R. China.; Li D

Subjects: Xenograft Model Antitumor Assays*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage ; Nanoparticles/Nanoparticles/Nanoparticles/*administration & dosage

  • Source: Oncology reports [Oncol Rep] 2010 Mar; Vol. 23 (3), pp. 717-24.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Antitumor activity of bevacizumab in combination with capecitabine and oxaliplatin in human colorectal cancer xenograft models.

Subjects: Xenograft Model Antitumor Assays*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*drug therapy

  • Source: Oncology reports [Oncol Rep] 2009 Aug; Vol. 22 (2), pp. 241-7.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Enhancement of capecitabine efficacy by oxaliplatin in human colorectal and gastric cancer xenografts.

  • Authors : Sawada N; Product Research Department, Kamakura Research Center, Chugai Pharmaceutical Co., Ltd., Kanagawa 247-8530, Japan. ; Kondoh K

Subjects: Xenograft Model Antitumor Assays*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*drug therapy

  • Source: Oncology reports [Oncol Rep] 2007 Oct; Vol. 18 (4), pp. 775-8.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Synergistic growth suppression induced in esophageal squamous cell carcinoma cells by combined treatment with docetaxel and heavy carbon-ion beam irradiation.

  • Authors : Kitabayashi H; Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.; Shimada H

Subjects: Xenograft Model Antitumor Assays*; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*drug therapy ; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*radiotherapy

  • Source: Oncology reports [Oncol Rep] 2006 Apr; Vol. 15 (4), pp. 913-8.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Lymphoma transformation of tumor infiltrating lymphocytes observed in testicular patient‑derived xenograft models.

  • Authors : Kalavska K; Translational Research Unit, Faculty of Medicine, Comenius University and National Cancer Institute, 83310 Bratislava, Slovakia.; Kucerova L

Subjects: Cell Transformation, Neoplastic/Cell Transformation, Neoplastic/Cell Transformation, Neoplastic/*pathology ; Lymphocytes, Tumor-Infiltrating/Lymphocytes, Tumor-Infiltrating/Lymphocytes, Tumor-Infiltrating/*transplantation ; Lymphoma/Lymphoma/Lymphoma/*pathology Testicular Germ Cell Tumor

  • Source: Oncology reports [Oncol Rep] 2018 Dec; Vol. 40 (6), pp. 3593-3602. Date of Electronic Publication: 2018 Oct 05.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  1,010 results for ""Xenograft Model Antitumor Assays""